Committed to developing treatments
for orphan diseases
Laurent Pharmaceuticals is an orphan drug company with a clinical development program in cystic fibrosis.
 |
 |
 |
Cystic Fibrosis |
Science |
LAU-7b |
Events
Laurent Pharmaceuticals to participate at the Biotech Showcase January 9-11th 2017, San Francisco, CA, USA
Laurent Pharmaceuticals to participate at the North American Cystic Fibrosis Conference, October 27th-29th 2016, Orlando, FL
News
Laurent Pharmaceuticals Receives FDA and Health Canada Clearance to Initiate APPLAUD Phase 2 Clinical Study of LAU-7b for the Treatment of Cystic Fibrosis
Laurent Pharmaceuticals Receives US$ 3M Development Award From Cystic Fibrosis Foundation Therapeutics
First Canadian Company To Obtain CFFT Therapeutics Development Award